FDA Drug Application (021266) for VFEND by PF PRISM CV

Back to FDA Applications sponsored by PF PRISM CV

Application Number021266
Product Number001
FormTABLET;ORAL
Dosage50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVFEND
Active IngredientVORICONAZOLE

Active IngredientCount
List of drugs with Active Ingredient VORICONAZOLE2


Back to FDA Applications sponsored by PF PRISM CV